Literature DB >> 11327478

Fecal shedding of Giardia duodenalis, Cryptosporidium parvum, Salmonella organisms, and Escherichia coli O157:H7 from llamas in California.

F C Rulofson1, E R Atwill, C A Holmberg.   

Abstract

OBJECTIVE: To evaluate fecal shedding of Giardia duodenalis, Cryptosporidium parvum, Salmonella organisms, and Escherichia coli O157:H7 from llamas in California with respect to host factors and management practices. ANIMALS: 354 llamas from 33 facilities. PROCEDURE: Fecal specimens were collected and examined for G. duodenalis and C. parvum by means of immunofluorescent microscopy. Salmonella organisms were cultured by placing feces into selenite enrichment broth followed by selective media. Escherichia coli O157:H7 was cultured by use of modified tryptocase soy broth followed by sorbitol MacConkey agar, with suspect colonies confirmed by means of immunofluorescent microscopy.
RESULTS: 12 of 354 fecal specimens (3.4%) had G. duodenalis cysts. Younger llamas (crias) were more likely to be shedding cysts, compared with older llamas. Farm-level factors that increased the risk of shedding were large numbers of yearlings on the property (> 10), smaller pen sizes, large numbers of crias born during the previous year (> 10), and large pen or pasture populations (> 20). None of the 354 fecal specimens had C. parvum oocysts. Seventy-six (from 7 facilities) and 192 (from 22 facilities) llamas were tested for Salmonella organisms and E. coli O157:H7, respectively. All fecal specimens had negative results for these bacteria. CONCLUSIONS AND CLINICAL RELEVANCE: Shedding of G. duodenalis was primarily limited to crias 1 to 4 months old. Llamas from properties with large numbers of crias born in the previous year, resulting in large numbers of yearlings in the current year, were at greater risk of infection. In addition, housing llamas in smaller pens or pastures and managing llamas and crias in large groups also increased the risk of G. duodenalis shedding.

Entities:  

Mesh:

Year:  2001        PMID: 11327478     DOI: 10.2460/ajvr.2001.62.637

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  7 in total

Review 1.  Escherichia coli O157:H7: animal reservoir and sources of human infection.

Authors:  Witold A Ferens; Carolyn J Hovde
Journal:  Foodborne Pathog Dis       Date:  2010-11-30       Impact factor: 3.171

2.  Isolation of shiga toxin-producing Escherichia coli from a South American camelid (Lama guanicoe) with diarrhea.

Authors:  E C Mercado; S M Rodríguez; A M Elizondo; G Marcoppido; V Parreño
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

3.  Cryptosporidium parvum as a risk factor of diarrhea occurrence in neonatal alpacas in Peru.

Authors:  Luis A Gomez-Puerta; Armando E Gonzalez; Ana Vargas-Calla; Maria T Lopez-Urbina; Vitaliano Cama; Lihua Xiao
Journal:  Parasitol Res       Date:  2019-11-22       Impact factor: 2.289

4.  Molecular identification of Cryptosporidium spp. in alpacas (Vicugna pacos) in China.

Authors:  Qiyuan Zhang; Junqiang Li; Zhiguo Li; Chunyan Xu; Minyu Hou; Meng Qi
Journal:  Int J Parasitol Parasites Wildl       Date:  2020-06-20       Impact factor: 2.674

5.  Presence and molecular characterisation of Giardia and Cryptosporidium in alpacas (Vicugna pacos) from Peru.

Authors:  Hipólito Gómez-Couso; Luis M Ortega-Mora; Adriana Aguado-Martínez; Raúl Rosadio-Alcántara; Lenin Maturrano-Hernández; Luis Luna-Espinoza; Víctor Zanabria-Huisa; Susana Pedraza-Díaz
Journal:  Vet Parasitol       Date:  2012-01-28       Impact factor: 2.738

6.  First cross-sectional, molecular epidemiological survey of Cryptosporidium, Giardia and Enterocytozoon in alpaca (Vicugna pacos) in Australia.

Authors:  Anson V Koehler; Mohammed H Rashid; Yan Zhang; Jane L Vaughan; Robin B Gasser; Abdul Jabbar
Journal:  Parasit Vectors       Date:  2018-09-05       Impact factor: 3.876

7.  Neonatal diseases in llamas and alpacas.

Authors:  Claire E Whitehead
Journal:  Vet Clin North Am Food Anim Pract       Date:  2009-07       Impact factor: 3.357

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.